Revvity price target lowered to $115 from $120 at Raymond James

Raymond James lowered the firm’s price target on Revvity (RVTY) to $115 from $120 and keeps an Outperform rating on the shares. While Revvity had a “solid” Q2 report, reimbursement headwinds in China will weigh on growth for the rest of the year, the analyst tells investors in a research note. The firm thinks shares are undervalued and continues to see ~6% out-year organic growth with expanding margins that are underappreciated.